Trypanosoma brucei gambiense-iELISA: A Promising New Test for the Post-Elimination Monitoring of Human African Trypanosomiasis.
Geerts M, Van Reet N, Leyten S, Berghmans R, Rock KS, Coetzer THT, Eyssen LE, Büscher P.
Clin Infect Dis. 2021 Nov 2;73(9):e2477-e2483. doi: 10.1093/cid/ciaa1264.
PMID:32856049
Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Gehrig S, Efferth T.
Int J Mol Med. 2008 Oct;22(4):411-9.
PMID:18813846
Identification of Trypanosoma brucei gambiense in naturally infected dogs in Nigeria.
Umeakuana PU, Gibson W, Ezeokonkwo RC, Anene BM.
Parasit Vectors. 2019 Aug 27;12(1):420. doi: 10.1186/s13071-019-3680-8.
PMID:31455430
Trypanosoma brucei gambiense Spliced Leader RNA Is a More Specific Marker for Cure of Human African Trypanosomiasis Than T. b. gambiense DNA.
Ilboudo H, Camara O, Ravel S, Bucheton B, Lejon V, Camara M, Kaboré J, Jamonneau V, Deborggraeve S.
J Infect Dis. 2015 Dec 15;212(12):1996-8. doi: 10.1093/infdis/jiv337. Epub 2015 Jun 16.
PMID:26080371
The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human african trypanosomiasis.
Jackson AP, Sanders M, Berry A, McQuillan J, Aslett MA, Quail MA, Chukualim B, Capewell P, MacLeod A, Melville SE, Gibson W, Barry JD, Berriman M, Hertz-Fowler C.